Johnson & Johnson

Latest Headlines

Latest Headlines

J&J plant overhaul turning into 4-year project

William Weldon really is a piece of work. In January he told analysts the consumer products plant in Fort Washington, PA, would open in 2013.

J&J plant fixes behind schedule, hampering brands' return

Johnson & Johnson's manufacturing overhaul has hit some unexpected roadblocks.

J&J and Bristol-Myers ally on another potential hep C blockbuster

The two research powerhouses will conduct a drug-drug interaction study.

J&J pharma revenues tick upward on new products, overseas sales

Johnson & Johnson's first-quarter sales may have taken a hit, but its prescription drugs business actually grew.

Manufacturing issues continue to undermine J&J earnings

Manufacturing issues that have led to recalls and product shortages continue to be a drag on the earnings of Johnson & Johnson, but the company saw its first quarter profits rise by double digits.

Justice, J&J duel over Gorsky's contribution to kickback case

Alex Gorsky's name has surfaced in the U.S. government's Risperdal marketing lawsuit just weeks before he is supposed to step up into the role of CEO at Johnson & Johnson.

Australia, New Zealand, recall J&J hip implant components

Johnson & Johnson is facing more bad news over its metal-on-metal artificial hip implant products, this time in New Zealand and Australia.

J&J's $1.2B Risperdal fine 'ups the ante' for other cases

Johnson & Johnson's new Risperdal fine isn't just a whopping big penalty. It's a big stone tossed into the company's legal problems.

UPDATED: Judge hits J&J with $1.1B penalty in Risperdal case

Like other juries before it, an Arkansas panel found that the company's Janssen unit soft-pedaled the antipsychotic drug's risks.

J&J looks for workaround to ease Doxil shortage

The idea is to allow its former contract manufacturer to formulate the cancer drug, and then send it elsewhere for filling and packaging.